Giovanni Camussi Selected Research

Neoplasms (Cancer)

1/2023	Stroma-derived miR-214 coordinates tumor dissemination.
1/2023	Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
8/2022	Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target.
10/2020	Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming.
1/2020	Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.
6/2019	Salivary Extracellular Vesicle-Associated exRNA as Cancer Biomarker.
1/2019	Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis.
1/2018	IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
3/2016	Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
1/2016	Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Camussi Research Topics

Disease

44	Neoplasms (Cancer) 01/2023 - 06/2003
17	Inflammation (Inflammations) 01/2022 - 08/2002
13	Proteinuria 01/2020 - 10/2002
11	Reperfusion Injury 01/2023 - 08/2003
9	Hypoxia (Hypoxemia) 11/2019 - 01/2012
9	Acute Kidney Injury (Acute Renal Failure) 05/2019 - 01/2008
8	Fibrosis (Cirrhosis) 01/2022 - 11/2016
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 04/2003
7	Ischemia 01/2022 - 01/2011
7	Necrosis 01/2020 - 10/2002
6	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2009
6	Renal Cell Carcinoma (Grawitz Tumor) 11/2018 - 08/2002
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014 - 04/2003
5	Sepsis (Septicemia) 09/2022 - 10/2002
5	Glomerulonephritis 01/2021 - 06/2005
5	Infections 03/2010 - 10/2002
4	Chronic Renal Insufficiency 01/2022 - 01/2019
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 04/2003
4	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2010 - 07/2002
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2009 - 09/2006
3	Disease Progression 01/2023 - 01/2007
3	Burns 12/2022 - 01/2008
3	Carcinoma (Carcinomatosis) 08/2022 - 09/2006
3	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2020 - 02/2003
3	Rhabdomyolysis 11/2016 - 05/2013
3	Kidney Neoplasms (Kidney Cancer) 12/2015 - 12/2011
2	Melanoma (Melanoma, Malignant) 01/2023 - 09/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021
2	Triple Negative Breast Neoplasms 08/2022 - 10/2020
2	Acute Coronary Syndrome 09/2021 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 09/2012
2	Hyperglycemia 01/2019 - 08/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017 - 07/2005
2	Pathologic Processes 11/2016 - 01/2016
2	Carcinogenesis 01/2014 - 02/2004

Drug/Important Bio-Agent (IBA)

18	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2011
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2002
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2014
10	nephrinIBA 09/2009 - 04/2003
8	CytokinesIBA 01/2022 - 07/2003
8	matrigelIBA 01/2019 - 09/2003
7	Messenger RNA (mRNA)IBA 11/2023 - 02/2006
6	Platelet Activating FactorIBA 10/2007 - 08/2002
4	Therapeutic UsesIBA 09/2022 - 01/2019
4	CateninsIBA 10/2021 - 05/2005
4	Complement System Proteins (Complement)IBA 01/2021 - 06/2003
4	Interleukin-3 (Interleukin 3)IBA 10/2020 - 07/2002
4	Urea (Carbamide)FDA LinkGeneric 01/2020 - 01/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2005
4	EnzymesIBA 01/2018 - 09/2003
4	AntigensIBA 08/2014 - 02/2006
4	Phospholipids (Phosphatides)FDA LinkGeneric 02/2006 - 08/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022 - 01/2011
3	salicylhydroxamic acid (SHAM)IBA 09/2021 - 05/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2003
3	erucylphosphocholineIBA 01/2021 - 10/2004
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
3	CreatinineIBA 01/2020 - 01/2008
3	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2018
3	SteroidsIBA 01/2017 - 07/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2004
3	Glycerol (Glycerine)FDA LinkGeneric 11/2016 - 10/2010
3	Cadherins (E-Cadherin)IBA 03/2016 - 05/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 01/2009
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2010 - 04/2006
3	Angiotensin IIIBA 01/2009 - 04/2003
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2008 - 07/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 04/2006
2	Phenobarbital (Luminal)FDA Link 08/2022 - 12/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 03/2004
2	AutoantibodiesIBA 10/2020 - 06/2003
2	aristolochic acid I (aristolochic acid)IBA 01/2020 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2019 - 05/2015
2	ImmunosorbentsIBA 01/2018 - 08/2014
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 08/2014
2	CaspasesIBA 01/2018 - 01/2015
2	Erythropoietin FDA Link 11/2016 - 07/2013
2	LipopolysaccharidesIBA 04/2016 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 03/2016 - 01/2014
2	NestinIBA 03/2016 - 10/2008
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 02/2004
2	Nucleic AcidsIBA 01/2016 - 01/2016
2	Conditioned Culture MediaIBA 04/2015 - 10/2009
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2014 - 08/2010
2	Caspase 3 (Caspase-3)IBA 08/2014 - 10/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 12/2006
2	Interleukin-15 (Interleukin 15)IBA 02/2013 - 12/2011

Therapy/Procedure

19	Therapeutics 10/2020 - 01/2006
6	Transplantation 01/2023 - 10/2008
3	Intravenous Injections 10/2020 - 10/2010
3	Liver Transplantation 01/2020 - 01/2013
3	Immunotherapy 01/2016 - 12/2011
2	Percutaneous Coronary Intervention 09/2021 - 01/2021
2	Subcutaneous Injections 01/2020 - 03/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 11/2016
2	Kidney Transplantation 01/2015 - 02/2013
2	Drug Therapy (Chemotherapy) 01/2015 - 03/2010